ACS Unveils Extended Vaping Guide to Help Retails Navigate Disposable Ban

Nov.19.2024
ACS Unveils Extended Vaping Guide to Help Retails Navigate Disposable Ban
The UK Association of Convenience Stores has released a guide on the legal sale of vaping products to help retailers prepare for the disposable vape ban set to take effect on June 1, 2025, ensuring compliance and avoiding penalties.

The Association of Convenience Stores (ACS) has released an expanded version of its "Selling Vapes Responsibly" guide to help retailers prepare for the disposable vape ban taking effect on June 1, 2025, Convenience Store reported on November 18.

 

The guide, developed in collaboration with the Bucks and Surrey Trading Standards, offers reliable compliance advice for retailers. It helps vape shops and other retailers understand how to meet the new regulatory requirements.

 

Under the updated rules, effective June 1, 2025, only rechargeable and refillable vapes will be legally sold, with disposable vapes banned. Unsold disposable vapes must be properly disposed of after the ban.

 

Retailers caught selling disposable vapes after the ban will face a fixed penalty of £200 and may be subject to further enforcement action if violations continue.

 

ACS chief executive James Lowman said the introduction of a ban on disposable vapes next year will have a significant impact on the thousands of retailers currently selling these products. 


“We have produced this guide to help retailers with the transition and ensure that nobody falls on the wrong side of the law on June 1st," said James.

 

"It is important that any retailer selling vapes not only prepares themselves for the change, but also communicates with customers on the implications of the ban to avoid any potential confrontations or flashpoints in store," he said.

 

The guidelines outline retailers' responsibilities for recycling vapes, including the proper collection, storage, and disposal of used devices, as well as arranging regular pickups. They also offer strategies for identifying illegal products, preventing sales to minors, and implementing the Challenge 25 system to support staff in verifying customers' ages.

 

For further information, visit the official guide at: acs.org.uk/advice/selling-vapes

 

STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
IVG Parent Secures HMRC Excise Warehouse and Duty Stamp Approvals Ahead of UK Vape Tax
IVG Parent Secures HMRC Excise Warehouse and Duty Stamp Approvals Ahead of UK Vape Tax
Acme Vape Ltd, the company behind UK vaping brand IVG, has received HM Revenue & Customs approval to operate an excise warehouse for vaping products and participate in the Vaping Duty Stamps Scheme. The UK's Vaping Products Duty will take effect on October 1, 2026, at a flat rate of £2.20 per 10ml of vaping liquid. Acme Vape Ltd says its approved warehouse in Preston will become operational under the new regime on the same date.
Regulations
Sep.18 by 2Firsts Perspectives
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
Ireland Raises Nicotine Product Taxes Again as Cigarettes Gain €1 and Vape Duty Is Set to Jump 40%
Ireland Raises Nicotine Product Taxes Again as Cigarettes Gain €1 and Vape Duty Is Set to Jump 40%
Ireland has increased tobacco excise under Budget 2027 and announced a further rise in its E-liquid Products Tax. From Oct. 7, the tax burden on a pack of 20 cigarettes in the most popular price category increased by €1, with pro-rata increases on other tobacco products. The government plans to raise EPT from €0.50 to €0.70 per millilitre from Jan. 1, 2027, a 40% increase applying to both nicotine-containing and nicotine-free e-liquids. The tobacco duty increase is expected to raise about €63.1 million in a full year.
Regulations
Oct.09
Product | Philip Morris Japan Teams Up With Renowned French Audio Brand DEVIALET for Limited-Edition IQOS Priced 60% Above Standard Model
Product | Philip Morris Japan Teams Up With Renowned French Audio Brand DEVIALET for Limited-Edition IQOS Priced 60% Above Standard Model
Philip Morris Japan (PMJ) launched the limited-edition IQOS ILUMA i PRIME Soundsorial Model in collaboration with French audio brand DEVIALET on October 1, 2026. Featuring sound-wave patterns, a silver-and-black finish and a gradient holder, the heated tobacco device is priced at JPY 15,980, including tax, and is available at four IQOS stores in Japan. According to Japanese media citing a PMJ representative, about 1,900 units were allocated to the Japanese retail market. A separate Soundsorial Collection, combining the device with DEVIALET Gemini II earbuds, includes 440 sets allocated to Japan for a membership prize draw.
product
Oct.23
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25